Core Financial Statements From 2010 to 2026

CLB Stock  USD 18.16  0.03  0.17%   
Core Laboratories' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Core Laboratories' valuation are provided below:
Gross Profit
103.2 M
Profit Margin
0.0621
Market Capitalization
850.2 M
Enterprise Value Revenue
1.7985
Revenue
517.5 M
We have found one hundred twenty available fundamental signals for Core Laboratories NV, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Core Laboratories NV prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. As of January 6, 2026, Market Cap is expected to decline to about 694.1 M. In addition to that, Enterprise Value is expected to decline to about 831.7 M

Core Laboratories Total Revenue

617.87 Million

Check Core Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Core Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 21.7 M, Interest Expense of 10.2 M or Selling General Administrative of 34.9 M, as well as many indicators such as Price To Sales Ratio of 2.65, Dividend Yield of 0.002 or PTB Ratio of 2.75. Core financial statements analysis is a perfect complement when working with Core Laboratories Valuation or Volatility modules.
  
Build AI portfolio with Core Stock
Check out the analysis of Core Laboratories Correlation against competitors.

Core Laboratories Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets553.5 M679 M587.5 M
Slightly volatile
Short and Long Term Debt Total219.5 M207.2 M255.5 M
Very volatile
Other Current Liabilities48.9 M35.7 M48.1 M
Slightly volatile
Total Current Liabilities100.8 M112.2 M105.1 M
Very volatile
Property Plant And Equipment Net121.7 M176.6 M140.2 M
Slightly volatile
Net Debt186.6 M185.1 M232.5 M
Very volatile
Retained Earnings193.2 M172.8 M189.5 M
Slightly volatile
Accounts Payable36.4 M39.7 M37.9 M
Pretty Stable
Cash30 M22 M18.3 M
Very volatile
Non Current Assets Total327.7 M418.4 M363.5 M
Slightly volatile
Cash And Short Term Investments30 M22 M18.3 M
Very volatile
Net Receivables129.6 M146.5 M134.9 M
Pretty Stable
Common Stock Shares Outstanding40.7 M42.9 M45 M
Very volatile
Liabilities And Stockholders Equity553.5 M679 M587.5 M
Slightly volatile
Non Current Liabilities Total267 M270.3 M324.3 M
Very volatile
Inventory40.5 M68.3 M46.4 M
Slightly volatile
Other Current Assets25.8 M23.8 M24.7 M
Very volatile
Total Liabilities367.8 M382.6 M429.3 M
Very volatile
Property Plant And Equipment Gross565 M538 M224.6 M
Slightly volatile
Total Current Assets225.8 M260.6 M224 M
Very volatile
Short Term Debt13.9 M12.3 M10.5 M
Slightly volatile
Intangible Assets5.5 M5.8 M9.2 M
Slightly volatile
Common Stock Total Equity1.1 M1.4 M1.2 M
Slightly volatile
Common Stock513.5 K540.5 K984.9 K
Slightly volatile
Other Liabilities66.4 M86.9 M80.7 M
Slightly volatile
Other Assets271.6 M258.7 M98.4 M
Slightly volatile
Long Term Debt224.1 M145 M230 M
Slightly volatile
Property Plant Equipment129.5 M176.6 M136 M
Slightly volatile
Current Deferred Revenue11.1 M10.7 M11.2 M
Slightly volatile
Good Will117.6 M89.5 M144.8 M
Slightly volatile
Warrants7.1 MM8.7 M
Slightly volatile
Non Current Liabilities Other46.6 M23.8 M41.5 M
Very volatile
Long Term Debt Total197.7 M113.5 M234.9 M
Slightly volatile
Capital Surpluse75.1 M126 M64.5 M
Slightly volatile
Deferred Long Term Asset Charges81.3 M77.4 M39.2 M
Slightly volatile
Short and Long Term Debt239.9 M204.7 M255.1 M
Slightly volatile
Long Term Investments4.2 M5.8 M3.6 M
Slightly volatile
Cash And Equivalents16.4 M22 M15.4 M
Slightly volatile
Net Invested Capital276 M340.3 M351.7 M
Slightly volatile
Net Working Capital122 M148.4 M110.3 M
Slightly volatile
Capital Stock773.1 K423 KM
Slightly volatile
Capital Lease Obligations48.3 M48.6 M67.5 M
Slightly volatile

Core Laboratories Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization21.7 M17.2 M20.7 M
Pretty Stable
Selling General Administrative34.9 M44.4 M41.6 M
Pretty Stable
Total Revenue617.9 M602.4 M661.8 M
Slightly volatile
Gross Profit169.8 M101.6 M178.8 M
Slightly volatile
Other Operating Expenses499.5 M535.1 M535.6 M
Pretty Stable
EBIT122.1 M67.1 M132.5 M
Slightly volatile
EBITDA143.7 M84.3 M153.2 M
Slightly volatile
Cost Of Revenue448 M500.8 M482.9 M
Pretty Stable
Total Operating Expenses51.4 M34.3 M52.7 M
Very volatile
Selling And Marketing Expenses2.2 M1.2 M1.8 M
Slightly volatile
Interest Income13.6 M14.2 M12.5 M
Pretty Stable
Reconciled Depreciation15.8 M13.5 M21.3 M
Slightly volatile
Non Recurring97.8 M110 M120 M
Slightly volatile

Core Laboratories Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow87.1 M49.9 M103.8 M
Slightly volatile
Begin Period Cash Flow29.5 M17.4 M24.6 M
Slightly volatile
Depreciation21.7 M17.2 M20.7 M
Pretty Stable
Dividends Paid1.6 M1.7 M44.2 M
Slightly volatile
Capital Expenditures16.7 M11.7 M19.3 M
Slightly volatile
Total Cash From Operating Activities110 M64.8 M123.7 M
Slightly volatile
End Period Cash Flow30 M22 M18.3 M
Very volatile
Stock Based Compensation4.1 M4.3 M15.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.651.393.9573
Slightly volatile
Dividend Yield0.0020.00210.0131
Pretty Stable
Days Sales Outstanding90.2910278.6818
Slightly volatile
Free Cash Flow Yield0.02470.04810.0341
Pretty Stable
Operating Cash Flow Per Share1.741.082.7082
Slightly volatile
Stock Based Compensation To Revenue0.00610.00650.0223
Pretty Stable
Capex To Depreciation1.171.00.9414
Slightly volatile
EV To Sales2.891.674.3102
Slightly volatile
Free Cash Flow Per Share1.40.832.2802
Slightly volatile
Inventory Turnover12.498.4310.949
Slightly volatile
Days Of Inventory On Hand27.7944.8136.3957
Slightly volatile
Payables Turnover9.9411.3412.7218
Pretty Stable
Sales General And Administrative To Revenue0.05320.06630.0644
Slightly volatile
Capex To Revenue0.04570.02860.0296
Pretty Stable
Cash Per Share0.460.370.3871
Pretty Stable
POCF Ratio17.4612.9624.4452
Very volatile
Capex To Operating Cash Flow0.440.270.2344
Slightly volatile
PFCF Ratio17.6916.8531.9699
Pretty Stable
Days Payables Outstanding33.1933.329.3117
Pretty Stable
EV To Operating Cash Flow19.2615.5327.5157
Very volatile
EV To Free Cash Flow21.220.1936.4547
Pretty Stable
Intangibles To Total Assets0.330.210.2881
Slightly volatile
Net Debt To EBITDA1.311.982.0078
Slightly volatile
Current Ratio2.662.672.1995
Slightly volatile
Receivables Turnover3.693.74.7293
Slightly volatile
Graham Number8.018.111.2386
Slightly volatile
Capex Per Share0.340.250.4279
Slightly volatile
Revenue Per Share9.4910.0514.3052
Slightly volatile
Interest Debt Per Share3.493.695.6867
Very volatile
Debt To Assets0.30.270.4072
Pretty Stable
Enterprise Value Over EBITDA13.8111.9520.5456
Pretty Stable
Short Term Coverage Ratios6.466.811.8521
Slightly volatile
Operating Cycle128159116
Slightly volatile
Days Of Payables Outstanding33.1933.329.3117
Pretty Stable
Price To Operating Cash Flows Ratio17.4612.9624.4452
Very volatile
Price To Free Cash Flows Ratio17.6916.8531.9699
Pretty Stable
Ebt Per Ebit0.670.710.8615
Slightly volatile
Long Term Debt To Capitalization0.380.30.5602
Slightly volatile
Total Debt To Capitalization0.410.380.591
Pretty Stable
Quick Ratio2.171.971.7301
Very volatile
Dividend Paid And Capex Coverage Ratio1.833.412.202
Very volatile
Net Income Per E B T0.540.610.7673
Very volatile
Cash Ratio0.320.230.1838
Very volatile
Cash Conversion Cycle95.3212687.1112
Slightly volatile
Operating Cash Flow Sales Ratio0.120.09690.16
Slightly volatile
Days Of Inventory Outstanding27.7944.8136.3957
Slightly volatile
Days Of Sales Outstanding90.2910278.6818
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.480.690.7585
Slightly volatile
Cash Flow Coverage Ratios0.380.280.4838
Slightly volatile
Fixed Asset Turnover5.673.924.9485
Slightly volatile
Capital Expenditure Coverage Ratio3.613.95.4936
Slightly volatile
Price Cash Flow Ratio17.4612.9624.4452
Very volatile
Enterprise Value Multiple13.8111.9520.5456
Pretty Stable
Debt Ratio0.30.270.4072
Pretty Stable
Cash Flow To Debt Ratio0.380.280.4838
Slightly volatile
Price Sales Ratio2.651.393.9573
Slightly volatile
Asset Turnover1.211.021.1401
Slightly volatile
Gross Profit Margin0.20.150.2429
Slightly volatile

Core Laboratories Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap694.1 M730.6 M2.2 B
Slightly volatile
Enterprise Value831.7 M875.5 M2.4 B
Slightly volatile

Core Fundamental Market Drivers

Forward Price Earnings19.7628
Cash And Short Term Investments19.2 M

Core Upcoming Events

31st of January 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
31st of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Core Laboratories Financial Statements

Core Laboratories stakeholders use historical fundamental indicators, such as Core Laboratories' revenue or net income, to determine how well the company is positioned to perform in the future. Although Core Laboratories investors may analyze each financial statement separately, they are all interrelated. For example, changes in Core Laboratories' assets and liabilities are reflected in the revenues and expenses on Core Laboratories' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Core Laboratories NV. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue10.7 M11.1 M
Total Revenue602.4 M617.9 M
Cost Of Revenue500.8 M448 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.07  0.05 
Capex To Revenue 0.03  0.05 
Revenue Per Share 10.05  9.49 
Ebit Per Revenue 0.10  0.13 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out the analysis of Core Laboratories Correlation against competitors.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.2
Dividend Share
0.04
Earnings Share
0.73
Revenue Per Share
11.096
Quarterly Revenue Growth
0.001
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.